Phreesia, Inc. (NYSE:PHR) Short Interest Up 27.4% in May

Phreesia, Inc. (NYSE:PHR - Get Free Report) was the recipient of a large increase in short interest in May. As of May 15th, there was short interest totalling 2,980,000 shares, an increase of 27.4% from the April 30th total of 2,340,000 shares. Approximately 5.4% of the company's shares are short sold. Based on an average daily trading volume, of 511,500 shares, the days-to-cover ratio is presently 5.8 days.

Insiders Place Their Bets

In other Phreesia news, SVP David Linetsky sold 3,944 shares of the company's stock in a transaction on Tuesday, April 8th. The stock was sold at an average price of $23.85, for a total transaction of $94,064.40. Following the transaction, the senior vice president now owns 221,738 shares of the company's stock, valued at approximately $5,288,451.30. This represents a 1.75% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, General Counsel Allison C. Hoffman sold 3,496 shares of the company's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $25.32, for a total value of $88,518.72. Following the transaction, the general counsel now directly owns 139,134 shares in the company, valued at approximately $3,522,872.88. This represents a 2.45% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 42,474 shares of company stock valued at $1,023,208. 5.50% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Phreesia

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Charles Schwab Investment Management Inc. boosted its stake in Phreesia by 10.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company's stock worth $12,415,000 after purchasing an additional 46,209 shares during the period. Barclays PLC boosted its stake in Phreesia by 83.6% in the 3rd quarter. Barclays PLC now owns 94,929 shares of the company's stock worth $2,163,000 after purchasing an additional 43,225 shares during the period. Deutsche Bank AG boosted its stake in Phreesia by 95.9% in the 4th quarter. Deutsche Bank AG now owns 57,297 shares of the company's stock worth $1,442,000 after purchasing an additional 28,047 shares during the period. Proficio Capital Partners LLC acquired a new position in Phreesia in the 4th quarter worth $377,000. Finally, M&T Bank Corp boosted its stake in Phreesia by 56.4% in the 4th quarter. M&T Bank Corp now owns 54,939 shares of the company's stock worth $1,382,000 after purchasing an additional 19,812 shares during the period. 92.10% of the stock is owned by institutional investors and hedge funds.

Phreesia Trading Up 3.9%

Shares of PHR traded up $1.00 during trading hours on Friday, reaching $26.78. The stock had a trading volume of 564,167 shares, compared to its average volume of 440,446. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia has a 52 week low of $17.07 and a 52 week high of $30.53. The firm has a 50-day moving average of $24.72 and a 200 day moving average of $25.41. The company has a market cap of $1.59 billion, a P/E ratio of -18.21 and a beta of 0.74.

Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, beating analysts' consensus estimates of ($0.13) by $0.06. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $115.94 million during the quarter, compared to analysts' expectations of $115.00 million. During the same quarter in the prior year, the company earned ($0.05) EPS. The firm's quarterly revenue was up 14.5% on a year-over-year basis. On average, sell-side analysts expect that Phreesia will post -1.1 earnings per share for the current fiscal year.

Analyst Ratings Changes

PHR has been the subject of several recent research reports. Needham & Company LLC reiterated a "buy" rating and set a $29.00 target price on shares of Phreesia in a research report on Thursday, March 13th. Truist Financial upped their target price on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research report on Thursday, May 29th. Canaccord Genuity Group dropped their target price on shares of Phreesia from $35.00 to $34.00 and set a "buy" rating for the company in a research report on Thursday, May 29th. DA Davidson dropped their target price on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Finally, Wall Street Zen upgraded shares of Phreesia from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $31.64.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.